Malignant melanoma is a devastating disease with a 5-year survival rate of approximately 20%.At the time of diagnosis, approximately 4% of patients had metastatic disease and between 5% and 20% had brain metastases.Most patients with intracranial metastatic melanoma have been treated with holocranial radiotherapy.Stereotactic radiosurgery is non-inferior to holocranial radiotherapy and has the advantage of preserving cognitive functions.This manuscript aims to show a case report of multiple melanoma metastases treated with stereotactic radiosurgery.
No takes yet. Share an insight, caveat, or question.
Duarte-Mora et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: